Label-free quantitative phosphoproteomics with novel pairwise abundance normalization reveals synergistic RAS and CIP2A signaling

Por Kauko, Otto, Laajala, Teemu Daniel, Jumppanen, Mikael, Hintsanen, Petteri, Suni, Veronika, Haapaniemi, Pekka, Corthals, Garry, Aittokallio, Tero, Westermarck, Jukka, Imanishi, Susumu Y.
Publicado no Sci Rep (2015)

Association of transcript levels of 10 established or candidate-biomarker gene targets with cancerous versus non-cancerous prostate tissue from radical prostatectomy specimens

Por Väänänen, Riina-Minna, Lilja, Hans, Cronin, Angel, Kauko, Leni, Rissanen, Maria, Kauko, Otto, Kekki, Henna, Vidbäck, Siina, Nurmi, Martti, Alanen, Kalle, Pettersson, Kim
Publicado em 2013

Oncoprotein CIP2A is stabilized via interaction with tumor suppressor PP2A/B56

Por Wang, Jiao, Okkeri, Juha, Pavic, Karolina, Wang, Zhizhi, Kauko, Otto, Halonen, Tuuli, Sarek, Grzegorz, Ojala, Päivi M, Rao, Zihe, Xu, Wenqing, Westermarck, Jukka
Publicado no EMBO Rep (2017)

Chk1 targeting reactivates PP2A tumor suppressor activity in cancer cells

Por Khanna, Anchit, Kauko, Otto, Böckelman, Camilla, Laine, Anni, Schreck, Ilona, Partanen, Johanna I., Szwajda, Agnieszka, Bormann, Stefanie, Bilgen, Turker, Helenius, Merja, Pokharel, Yuba R., Pimanda, John, Russel, Mike R., Haglund, Caj, Cole, Kristina A., Klefström, Juha, Aittokallio, Tero, Weiss, Carsten, Ristimäki, Ari, Visakorpi, Tapio, Westermarck, Jukka
Publicado em 2013